MRNA

MRNA Financing Cash Flow

$590.00MTTM · USD

Period ending:

MRNA FY Cash from FinancingUSD
MRNA FY Cash from Financing2016-12-31: $472.91M2017-12-31: $168.00K2018-12-31: $1.23B2019-12-31: $51.12M2020-12-31: $2.03B2021-12-31: -$873.00M2022-12-31: -$3.45B2023-12-31: -$1.38B2024-12-31: $56.00M2025-12-31: $593.00M$2.03B-$3.45B
2016-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

MRNA financing cash flow history

Cash from issuing/repaying debt and equity. The available annual fiscal periods series contains 10 observations from Dec 31, 2016 to Dec 31, 2025.

Moderna Financing Cash Flow — Annual fiscal periods (USD)
Period endingFinancing Cash Flow (USD)
593,000,000
56,000,000
-1,377,000,000
-3,448,000,000
-873,000,000
2,033,193,000
51,121,000
1,226,842,000
168,000
472,910,000

Compare financing cash flow

All MRNA financial metrics · MRNA stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.